Mr. Fu oversees the firm’s overall strategy, talent development and is responsible for maintaining the firm’s long-term partnerships with global investors. He has driven successful incubation and buyout strategies, shaping the firm’s differentiated investment approach. Under his leadership, CBC Group was recognized by PEI in 2024 as the #1 private equity firm in Singapore and Asia’s largest healthcare-focused firm, earning this title for the third consecutive year, with the Group’s AUM having grown from US$180 million in 2014 to US$10.5 billion today. 

He initiated and led investment transactions including Everest Medicines (HKEX 1952.HK), Hugel Inc. (KOSDAQ:145020), ENSEM Therapeutics (Boston, US) and I-Mab Biopharma (NASDAQ: IMAB), while also being instrumental in incubating several biotech and pharmaceutical companies. He serves as Chairman of the Board for Everest Medicines and I-MAB Biopharma respectively. 

Prior to founding CBC Group in 2014, he was formerly the General Manager of the investment department at a wholly owned subsidiary of Far East Horizon Limited (HKEX:3360). He has also worked for Standard Chartered Bank (China), Macquarie Capital (Singapore) and Temasek Holdings. 

Fu Wei graduated from Singapore’s Nanyang Technological University with a first-class honors degree in Electrical Engineering and a minor in Business Administration. He is a scholar of Singapore's Ministry of Education and a member of the prestigious Young President’s Organization.

Alex Shum is a Business Unit Partner of TPG NewQuest, based in Hong Kong. Alex joined TPG NewQuest in 2011 and is responsible for the sourcing, execution and portfolio management of investments across the Greater China and North Asia regions. Alex has more than 15 years of experience in finance across investments, capital raising, M&A and corporate advisory. Prior to joining TPG NewQuest, Alex was an Associate at Credit Suisse’s Investment Bank based in Hong Kong, where he worked in the corporate finance and equity capital markets departments. Alex received his undergraduate degree in Economics from Duke University. He is fluent in English, Mandarin and Cantonese.

Dr. Amit Kakar joined Novo Holdings Asia in August 2020 as Head of Asia to lead investments and partnerships across the region, focusing primarily on the markets in China, Southeast Asia and India. 

Dr. Kakar has more than 25 years of healthcare experience with several senior management roles across the globe and having worked in India, China, Singapore, Denmark and the USA. His previous roles include Head of M&A and Business Development at Everlife Asia, Head of Healthcare Investments for Asia with the Avenue Capital Group, and various senior leadership positions with GE Healthcare. 

Dr. Kakar is a Medical Doctor with a postgraduate degree in Radiation and Nuclear Medicine from Tata Memorial Hospital and Cancer Centre in Mumbai, India.

Andrew Li joined Advent in 2012 and is a Managing Director in Shanghai. He advises on investments in the consumer, healthcare, and industrial sectors. Andrew has advised on 16 investments during his career, nine while at Advent. 

Prior to joining Advent, Andrew worked at Warburg Pincus, Solera Capital, and Credit Suisse throughout China and the US, where he focused on the energy, healthcare, industrial, and retail and consumer sectors. 

Andrew holds a BA from Middlebury College and an MBA from Harvard Business School.

Mr. Huang is Head of Cross-Border Investment / M&A and Co-Head of Global Consumer at FountainVest Partners. He joined FountainVest in 2017. 

Mr. Huang sits on the boards of Amer Sports, Ziwi, Windrose Technology, and CFB Group. He previously sat on boards of Precor, Suunto and Trendy International. Prior to joining FountainVest, Mr. Huang spent 13 years with Goldman Sachs based in Hong Kong and New York, including as a Managing Director in the Mergers & Acquisitions Group and Head of China M&A. 

Mr. Huang holds an MBA in Finance from the Wharton School and a Bachelor of Arts in Economics and Political Science from Columbia University.

Chang Liu (Chinese) is an Executive Director at LGT Investment Consulting (Beijing) Ltd., People's Republic of China. As part of the Asia private equity team, he is responsible for origination, due diligence and monitoring of private equity investments in Asia. He also leads the firm’s local business development efforts in mainland China. 

Prior to joining the firm in 2019, he was a senior associate at HarbourVest Partners in Beijing, focused on primary investments in the region. 

Mr. Liu holds a Bachelor's degree in Mathematics and Economics from Brandeis University. He is fluent in English and Mandarin.

Charles joined CDH in 2018 and leads an investment team focused on Advanced Manufacturing & Technology. He is now a member of investment committee of CDH Private Equity. Prior to joining CDH, Charles was a Founding Partner with KYI Capital , a private equity firm focusing on core technology investments, and a Managing Partner with Beijing Semi Fund, a private equity firm focusing on semiconductor investments. Prior to that, Charles was a Director with CVCi and a Senior Engagement Manager with McKinsey & Company. He received his M.B.A. from IMD Business School in Switzerland and his B.E. in Electrical Engineering & Computer Science from Shanghai Jiaotong University.

David Selvia is a Partner at The Cathay Capital Group (CCG), a multi-bb series of China-focused growth equity funds. From the early 90s Cathay’s funds have led investments into 50+ businesses with exits by way of MNC trade sales, and A Share, HKSE, NYSE & Nasdaq IPOs.

 David has 25+ years of investment experience in Asia. From 2000-2004 David led M&A/BD for various General Electric industrial business units, before then spearheading GE Capital’s China market entry. During his time at GE David was involved in dozens of new investments, JVs, partnerships as well as distressed workouts. Joining Cathay in 2006 in Hong Kong David went on to establish CCG’s Shanghai office before relocating to lead its Beijing operations. Currently David is responsible for new investments as well as cross-border initiatives.

 David holds a BA from Boston University, an MBA from UPenn’s Wharton School and an MA from UPenn’s Lauder Institute. He has served on dozens of boards, both public and private. David is based in Shanghai, and speaks Mandarin.

Mr. Lai is responsible for originating, evaluating, negotiating, and monitoring of private equity investments in Asia. He joined Manulife in 2020. Prior to that, he was a senior member of the private equity group at Full Vision Capital, where he was responsible for private equity investments globally and driving strategic and operational changes at portfolio companies. He also worked in the the private equity group at China Merchants Securities. Mr. Lai hold a bachelor’s degree in Economics from University College London and a Graduate Diploma in Law from BPP Law School.

 方远是星界资本的创始管理合伙人，负责公司股权母基金投资及ESG实践。星界资本成立于2017年，是一家新兴的市场化私募股权投资机构，专注科技、消费和医疗领域投资。在方远先生的领导下，星界资本成为第一个加入联合国负责任投资原则组织的人民币母基金私募股权投资机构及首个获得联合国负责任投资原则组织2019年度奖项“新兴市场年度领袖”的亚洲机构。

2025年方远先生被委任为香港联交所上市委员会成员，成为首个入选的母基金行业成员，开创了母基金行业先河。

在创建星界资本之前，方远先生担任欧洲最大的家族主权基金LGT资本中国区总裁12年。LGT资本由列支敦士登王室家族所有，管理超过1000亿美元的资产。方远先生在中国私募股权中一共投资了超30亿美元，包括鼎晖投资、中信资本、红杉中国、君联资本等老牌基金，及源码资本、愉悦资本、高榕创投等新一代基金，并担任20多只基金的顾问委员会成员。

方远先生积极参与公共服务。在教育领域，方远先生是清华大学经济管理学院金融硕士项目的行业导师，中欧国际工商学院CEIBS创业营的行业顾问，上海交通大学正阳奖学金的创始人及捐赠人，以及欧洲工商管理学院INSEAD Frankie Fang奖学金的创始人及捐赠人。在社会服务领域，方远先生是中国证券投资基金业协会的母基金委员会委员、福布斯中国2020年“30 Under 30”风险投资领域的评委、未来论坛青年理事会成员（该理事会设立了被誉为“中国诺贝尔奖”的未来科学大奖），以及美丽中国教育公益项目的捐赠人。

方远先生于2000年毕业于上海交通大学安泰经济与管理学院，获金融与会计学士学位；2006年毕业于INSEAD，获工商管理硕士学位；2018年毕业于清华大学五道口金融学院，获EMBA学位。方远先生拥有中国注册会计师资格。他的母语是普通话，同时精通英语、法语和粤语，具备日语会话能力。

Helen Wong is a Managing Partner at AC Ventures (ACV), an early-stage, Indonesia- focused technology venture capital fund. ACV manages five funds with an AUM of over US$500M and a portfolio of more than 120 businesses invested in the past eight years. The firm has led investments into Stockbit, Xendit, Shipper, Carsome and more.   

Forbes magazine ranked her among China’s “Top 25 female VCs” and “Top 100 investors”. Forbes also ranked her as one of three Singaporeans among the Top “50 over 50” in Asia Pacific in 2024. Helen is a venture capitalist with a strong track record (over 20 years of experience), as she was part of the founding team at GGV Capital, and served as a Partner at Qiming Ventures.   

Helen started her career in Silicon Valley/US, then moved to China, and now covers Southeast Asia. She led investments in Akulaku (a fintech unicorn) and Simplus in SE Asia, and has served the boards of highprofile Chinese internet companies. She has had 10 exits (7 IPOs and 3 M&As) among her portfolio companies including Tudou and QuantaSing on NASDAQ, Buchang on the Shanghai stock exchange, and Mobike (acquired by Meituan). 

Helen graduated with a B.A. degree from Oxford University and a M.B.A. from INSEAD. She also has an E.M.B.A. degree from Cheung Kong Graduate School of Business in China. She is a Kauffman Fellow, and also participated in the China European International Business School (“CEIBS”) venture capital program.   

Ian Goh is a seasoned investor in the technology space with over 18 years of experience. He is the Founding Partner at 01VC, an early-stage venture firm focused on cross-border, supply chain, and deep tech investments. Ian has been an early investor in and board member of some of the most innovative companies in recent years, including Lalamove, XTransfer, and Hai Robotics. He also participated in the early investment in Baidu, one of China’s most iconic internet companies.

He has served on the boards of several public and acquired companies, such as Zhaogang.com (HKSE: 6676.HK), 7gege (acquired by La Chapelle, HKSE: 06116.HK), IN (NEEQ: 836484), Cgen Media (acquired by Nasdaq-listed Focus Media), Kanghui (acquired by Medtronic, NYSE: MDT), Madhouse.cn (acquired by BlueFocus, SZ: 300058), and A8.com (HKSE: 0800.HK).

Prior to founding 01VC, Ian was a Partner at Matrix Partners China, focusing on consumer internet and transaction platforms. He began his venture career in 2004 at TDF Capital, which later merged into Kleiner Perkins Caufield & Byers China, where he also served as Partner. Ian first came to China in 2001 to join Lycos Asia, one of the early internet pioneers, where he held corporate and business development roles.

He also played a strategic role in helping Kuadi Dache acquire its competitor Dahuangfeng, and introduced GrabTaxi to Didi Chuxing at a formative stage.

Born in Singapore and later educated in Australia, Ian holds a Bachelor of Commerce from Murdoch University. He is both a CFA charterholder and a qualified Chartered Accountant.

Jason has over 18 years of experience in private equity, fund management, and investment banking. He was most recent with GLP Capital Partners, a global alternative asset manager with approximately US$125 billion in assets under management focusing on real assets and private equity, where he led investments in Greater China and Southeast Asia, in addition to overseeing and managing GLP’s investment in China Merchants Capital, one of China’s largest private equity investment platforms with US$47 billion in assets under management. Previously he was the Head of PIPE Investments at China Everbright Limited, a Chinese private equity and asset management platform, where he managed principal and third-party capital and invested in pre-IPO and late-stage Chinese companies. Before that, he was the Head of Direct Investment and a Managing Director at China Huarong Asset Management where he managed a US$1 billion portfolio of structured credit and mezzanine debt of Chinese companies. 

Before entering the private equity industry, Jason spent close to a decade as an investment banker at Citi and Standard Chartered Bank where he was responsible for advising and executing capital markets transactions and M&A for Chinese and Hong Kong corporates and global private equity funds, completing approximately US$5 billion of M&A transactions and US$10 billion of capital markets deals. 

Jason graduated cum laude from Columbia University with a B.S. in Industrial Engineering Operations Research and Economics.

Vice President of Shenzhen Capital Group, member of the Investment Committee. His responsibilities include leading departments that handle fundraising, project investment and post-investment services. He has extensive experience in investment and financing, as well as corporate management. He has management experience in government FoFs with AUM exceeding 100bn RMB.

Dr. LI Yao currently is the Chief Investment Officer for East Asia and Pacific Department of IFC, World Bank Group, based in Hong Kong. As the regional Climate Business Anchor and the regional South-South Business Anchor, he focuses on promoting Climate investment, South-South Outbound Investment, and Impact investment in the region. During his professional career before IFC, He took several top managerial roles with China Stated owned large sized financial institutions. Dr. LI also was with DRC of China State Council as the policy researcher on China opening policies in early 1990’s. 

Dr. LI holds PhD degree in Economics. His academic interests include the Global Sustainable Growth, the Transition Economics for Developing Countries.

Ling Yang is China Editor for Mergermarket, a global news intelligence service for advisors, private equity firms and corporates. She heads a team of dedicated specialists across China to cover corporate growth strategies, M&A deals, PE buyouts, cross-border M&A intelligence, as well as data-backed analysis and trend pieces.

Ling has been an investigative M&A reporter for 12 years with a special focus on private equity coverage. She was the head of consumer and retail coverage for APAC with Mergermarket. She joined Mergermarket in Hong Kong in 2011 before moving to Shanghai in 2016.

Perris Lee is the Asia ECM Editorial and Insights Director for ION Analytics. He looks after potential and live IPO, follow-on, and equity-linked bond deals, as well as producing the data-driven, forward-looking column “ECM Explorer APAC.”

Perris joined ION Analytics/Acuris in 2011 as the Taiwan correspondent for Dealreporter, covering both ECM and M&A matters. Soon after becoming a well-versed Taiwan-subject expert catering primarily to global hedge funds and proprietary desks, Perris expanded his mandate to include Asia convertible bonds in 2014 and further to Asia ECM in 2015. He was promoted to his current role in 2021.

Prior to joining ION Analytics, Perris spent nine years covering the Asian financial markets for Dow Jones Newswires and Bloomberg.

Sheng Liu is Head of Partners Group's China office and part of the Private Equity Health and Life business unit, based in Singapore. He is a member of the Health and Life Vertical Investment Committee as well as a member of the Board of Directors of the firm's portfolio companies Apex Logistics, Green Tea restaurant and Aiyingshi. He has been with Partners Group since 2013 and has 21 years of industry experience. Prior to joining Partners Group, he worked at Cathay Capital Private Equity as Investment Director in charge of both investment and value creation, and before that at KPMG. He holds a bachelor’s degree in finance from the Shanghai University of Finance and Economics, China.

Tim Burroughs is managing editor of Asian Venture Capital Journal, having joined the publication in May 2011. He is responsible for all editorial content put out under the AVCJ brand, including Asian Venture Capital Journal, AVCJtv, AVCJ Awards and AVCJ.com. Tim previously spent five years at China Economic Review, serving as editor-in-chief and then editorial director. Located in Greater China since 2003, during which time he has lived in Beijing, Qingdao and Hong Kong, Tim has been a China-based contributor for publications including The Sunday Times, Sunday Telegraph, BBC and China Daily. Prior to moving to China, he trained and worked as a journalist in the UK. He was honored at the Society of Publishers in Asia awards in 2007, 2008 and 2010, and at the State Street Institutional Press Awards - Asia in 2012.

Ms. YARONG LA has 19 years of experience in finance and a 3-year entrepreneurial background. Since joining ORIZA FOFs in 2021, she has been primarily responsible for external partnerships, fundraising, investor relations, and public relations. 

Ms. LA has led her team in expanding and onboarding institutional investors, including financial institutions and state-owned capital, systematically establishing a professional fundraising framework. She has driven the structural transformation and upgrade of ORIZA FOFs’ LP base, building a top-tier institutional investor network in the market. Innovatively fostering collaborations with various institutional investors, she has spearheaded the design and execution of diverse partnership models— from fund structuring to investment strategy—playing a pivotal role in diversifying ORIZA FOFs’ asset classes and pioneering new cooperation approaches. Additionally, she has refined the LP service system and public relations framework, delivering comprehensive and precise pre- and postinvestment services to LPs. 

Ms. LA has been recognized as the Top 10 Most Popular IR Professionals, Top 20 Women in China’s Institutional LP Sector, and Top 20 Influential “Her Power” Figures in the industry. She previously served as a fundraising partner at a leading domestic wealth management firm, where she honed her expertise in fund financing, operations, and management, amassing extensive experience and resources

Yiqing Wang is Managing Editor of Mergermarket’s Asia-Pacific M&A and ECM editorial team, which specializes in breaking news on private and public M&A transactions and delivering forward-looking intelligence on corporate strategy. Yiqing spearheads the editorial strategy and oversees day-to-day operations, to deliver timely, actionable insights and analysis to help clients make better deal-making and investment decisions. Additionally, she frequently moderates panels and chairs conferences at ION Analytics events, bringing industry insights to the forefront.

She has been an investigative M&A reporter and editor since 2009, writing news ranging from healthcare, renewable energy and financial service, etc.

Yiqing achieved her master's degree of multilingual multicultural studies from New York University.

叶卉女士于 2017 年加入蔚来资本，领导了美元基金募集设立及被投企业嘀嗒、嬴彻、奥动的投后管理工作。叶卉女士在中国 PE/VC 行业拥有 10 年从业经验。

在加入蔚来资本之前，叶卉女士曾任职于弘毅投资工业投资组。她持有波士顿大学金融数学硕士学位及复旦大学金融学士学位。

1. 作为毕马威中国金融行业主管合伙人、资产管理行业主管合伙人和私募股权行业联席主管合伙人，吴先生为私募股权基金、主权基金及国企客户提供过众多里程碑项目的尽调服务。
2. Louis与其客户就毕马威如何在提供更严谨有针对性的尽调工作及价值创造保持持续动态交流，并持续关注科技、关税和ESG等关键因素的影响，以帮助我们的客户在投资环境得到更多的保护和增值
3. 同时，Louis在2006年赴华任职之前，曾就职于毕马威新加坡及伦敦分公司，对经济环境及地缘政治对金融行业的影响、全球PE行业动态、及中外金融环境具备一定专业积累。在就职专业领域广泛联络相关国内外交易咨询行业专业人士、客户、同事及潜在投资者，对中外PE行业交流具有积极的推动作用

Rebecca Xu is a Co-Founder and Managing Director of Asia Alternatives. Ms. Xu splits her time between Asia Alternatives’ Beijing, Shanghai and Hong Kong offices. Ms. Xu is on the Firm’s Investment Committee and co-leads Asia Alternatives’ investments in growth and venture capital funds, focusing most of her time on Asia Alternatives’ China investments. 

Prior to starting Asia Alternatives, Ms. Xu was a Senior Investment Officer at the Funds Group of the International Finance Corporation (“IFC”), the private sector investment arm of the World Bank Group. There, she had the primary responsibility of leading IFC’s fund investing and portfolio supervision in Asia for over six years. Previously, Ms. Xu also worked at McKinsey & Co, Inc. (Washington D.C.) and HSBC (Hong Kong). 

Ms. Xu received an M.B.A. from Harvard Business School and holds a Bachelor’s degree in International Relations from the Foreign Affairs College in Beijing, China. Ms. Xu is fluent in Mandarin Chinese. 

Ms. Xu currently serves on the Advisory Boards for a number of Asia Alternatives’ China and India private equity funds. In addition, she serves as the Chairwoman of the Hong Kong Venture Capital and Private Equity Association (HKVCA) and on the Board of the Chun Hui Bo’ai Children’s Foundation.

Maryann Tseng is Head of International Capital Markets, and Senior Managing Director of Strategic Investment Department at SenseTime Inc. 

SenseTime Inc is a Hong Kong Stock Exchange listed under ticker 0020.HK, with market capitalization of US$8.5bn artificial intelligence software services company. 

Prior to joining SenseTime Inc, Maryann was a highly recognized global markets and capital markets investment banker in Asia, mostly with Morgan Stanley; often highly ranked by Institutional Investor and Asia Money. 

Maryann holds adjunct associate professorship at Hong Kong PolyTech University; sits on the corporate advisory board of HKUST MSc Business Analytics program. She is a CIMA CGMA fellow; received Executive Education from Harvard Business School and Stanford University Business School and Law School. 

She now is based in Hong Kong, but travel frequently to key markets and countries globally for investors engagements, business commercialization and developments.

Leigh joined Han Kun Law Offices in 2012 and is a partner in the firm's Investment Fund Team. Based in Shanghai, Leigh frequently travels to the Greater Bay Area and Singapore to manage client relationships in those regions.  She focuses her practice on investment fund formation and operation, asset management, and foreign direct investment, with a particular emphasis on private equity and venture capital. Leigh possesses extensive expertise in RMB and US dollar fund formation, as well as significant experience in cross-border investment matters, including QFLP, QDLP/QDIE, QFII, and QDII. 

Educational background

Sun Yat-sen University, LL.B.

Columbia Law School, LL.M. (with honors)

Seoul National University, LL.M.

INSEAD, Global Executive MBA (Class of 2025)

Zhan is an Investment Principal and General Manager of Coller’s Beijing office. He is responsible for origination and execution, and is based in the firm’s Hong Kong and Beijing offices.

Prior to joining Coller Capital in 2016, Zhan was a Director at BlackRock Private Equity Partners. Previously, he worked at Swiss Re Private Equity Partners and Adveq Management in Zurich, Beijing and Hong Kong.

Zhan has a BEng in Environmental Engineering from Tianjin University, an MSc in Environmental Science from Nanyang Technological University and an MBA from INSEAD. Zhan is a CFA Charterholder.

Boyu Hu is the founder of XVC, a 2-billion USD research-driven venture capital fund. According to Preqin's latest league table, XVC II was ranked #1 best performing VC fund globally of the 2019 vintage in the 250-499 million category. 

Boyu excels at singling out 'big ideas' at early-stage, and the market value of his portfolio companies, which includes Kuaishou, Weee!, Hetao coding, Chagee, etc., reached over 50 billion USD. 

Before becoming an investor, Boyu had nearly 10 years of entrepreneurial experience. He co-founded China’s largest credit risk management software company, Amarsoft (SHE:300380).

Jingyi is a partner of Cooley’s fund formation practice. Her practice focuses on the formation and representation of private investment funds both in the United States and internationally. In particular, Jingyi specializes in representing fund managers investing in China in connection with the formation of their USD-dominated funds, including venture capital funds, private equity funds and project funds, as well as upper-tier arrangements, carried interest plans and various governance matters. Jingyi also represents institutional investors (including sovereign wealth funds and funds of funds) and other investors in connection with investments in private funds.

Jingyi has been recognized as a "Next Generation Partner" for Investment Funds practice in China by the Legal 500 Asia Pacific from 2022 to 2025. She is also recognized as one of the “2024 ALB China Top 15 Rising Lawyers” and the “2022 Rising Stars” by China Business Law Journal. 

郑力元先生于 2020 年 1 月加入 Investcorp，现任新兴市场联合负责人，负责海合会国家、东南亚和大中华区业务。他在任职期间的知名投资项目包括谷物食品品牌 VizBrands、陆道培血液肿瘤医疗集团、牙科 SaaS 服务商领健、高端制造商嘉诺等。

此前，郑力元先生在德国法兰克福知名私募股权公司Triton担任负责人， 早期曾在美国达拉斯投资机构Hicks Muse Tate & Furst任职，该机构旨在在欧洲和北美主导商业服务、工业和消费领域的控股权收购交易。郑力元先生的职业生涯始于纽约投行所罗门兄弟，他拥有波士顿学院管理和金融科学学士学位，以及清华大学五道口金融学院授予的产业与金融高管学位证书。

陈中崛先生是贝恩投资私募股权的合伙人，也是亚太私募股权团队的创始成员之一，常驻香港。陈先生于2005年加入贝恩资本，曾分别在波士顿和香港办事处工作，持续专注于科技、工业、金融和商业服务领域的成长资本和收购。在加入贝恩资本私募股权之前，陈先生在贝恩咨询波士顿办公室任职咨询顾问。早年他还在中国投资有限责任公司任职。

陈先生于哈佛大学商学院获得MBA学位，并以全优的成绩毕业于哈佛大学，获得经济学学士学位。

陈伟豪先生为大钲资本的董事总经理和投资决策委员会成员，于2019年加入大钲资本。目前，陈先生还担任瑞幸咖啡（OTC: LKNCY）的董事及可持续发展委员会的联席主席，安能物流（HKSE: 9956）的联席董事长及ESG委员会主席。陈先生在中国私募股权投资领域拥有丰富的投资和管理经验，在加入大钲资本之前，负责华平投资中国消费及服务业领域的投资。陈先生于2011年加入华平之前，曾在亚洲成长型基金公司Crescent Point公司担任副总裁。在此之前，陈先生任职于摩根士丹利香港投资银行部和埃森哲中国。他拥有复旦大学的经济学学士学位和INSEAD的M.B.A学位。

黃德炜先生为太盟投资集团合伙人、私市股权联席主管，负责统领私市股权策略部门的运营及管理。黄先生自2011年3月起加入太盟投资集团担任执行董事，自2014年4月起一直担任集团合伙人。黄先生是太盟投资集团管理委员会成员。  

黄德炜先生有25年的金融行业从业经验。加入太盟投资集团之前，黄先生于2006年至2010年曾任职于美国另类资产管理公司TPG，担任副总裁职务并负责亚洲地区股权投资的评估和执行。此前，他于1999年至2005年曾任职于摩根士丹利投资银行部，先后从事中国市场的并购和股权融资业务以及北美中型企业并购业务工作。

黄先生于1999年5月获得加州大学伯克利分校工商管理和亚洲研究学士学位。